MedTrace Logo

A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer

NCT04625023 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-05-01

No results posted yet for this study

Summary

METAMECH is a master observational protocol designed to empower a bi-directional collaboration between basic and clinical research, an essential prerequisite to feed and implement precision oncology.

METAMECH will follow a stage-mixed cohort of at least 500 patients through their course of treatments, until death or a minimum of 5 years. Patients will be longitudinally sampled and matched clinical data (including imaging) will be collected. Via a multi-tiered informed consensus process, METAMECH will also allow to develop companion diagnostics for molecular enrichment strategies in AIRC-driven proof-of-concept trials.

Conditions

Interventions

OTHER

Observational

Retrospective cohorts and Prospective observation of standard clinical practice

Sponsors & Collaborators

  • IFOM ETS - The AIRC Institute of Molecular Oncology

    lead OTHER

Principal Investigators

  • Silvia Marsoni, MD · IFOM ETS - The AIRC Institute of Molecular Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-16
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04625023 on ClinicalTrials.gov